Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-03-003820
Filing Date
2003-03-26
Accepted
2003-03-26 17:21:44
Documents
11
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 KOS PHARMACEUTICALS, INC. g81457e10vk.htm 10-K 719129
3 EX-10.16 3RD AMEND. & RESTATED REGI. RIGHTS AGREE. g81457exv10w16.txt EX-10.16 31479
4 EX-10.19 REVOLVING CREDIT & LOAN AGREEMENT g81457exv10w19.txt EX-10.19 82064
5 EX-10.20 REVOLVING CREDIT PROMISSORY NOTE g81457exv10w20.txt EX-10.20 14381
6 EX-10.21 NON-DETACHABLE STOCK PURCHASE WARRANT g81457exv10w21.txt EX-10.21 11822
7 EX-10.22 2ND AMEND. RESTATED SECURITY AGREEMENT g81457exv10w22.txt EX-10.22 59815
8 EX-21 SUBSIDIARIES OF THE COMPANY g81457exv21.txt EX-21 790
9 EX-23.1 CONSENT OF ERNST & YOUNG LLP g81457exv23w1.txt EX-23.1 1245
10 EX-23.2 NOTICE RE: CONSENT OF ARTHUR ANDERSEN LLP g81457exv23w2.txt EX-23.2 2730
11 EX-99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER g81457exv99w1.txt EX-99.1 1389
12 EX-99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER g81457exv99w2.txt EX-99.2 1397
  Complete submission text file 0000950144-03-003820.txt   929137
Mailing Address
Business Address 1001 BRICKELL BAY DR STE 25 MIAMI FL 33131 3055773464
KOS PHARMACEUTICALS INC (Filer) CIK: 0001018952 (see all company filings)

EIN.: 650670898 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22171 | Film No.: 03618982
SIC: 2834 Pharmaceutical Preparations